Skip to main content
. Author manuscript; available in PMC: 2026 Jul 12.
Published in final edited form as: Urology. 2025 Oct 16;207:233–238. doi: 10.1016/j.urology.2025.10.025

Table 1.

Patient characteristics.

Characteristic N = 319
Median age (IQR) 64 (48, 73)
Median BMI (IQR) 29 (26, 33)
Median follow up in patients without recurrence (mo) (IQR) 7.2 (3.4-12.8)
Primary stricture length (%)
 L1 - ≤2 cm 170 (65.9)
 L2 - > 2-≤7 cm 84 (32.6)
 L3 - > 7 cm 4 (1.6)
Primary stricture location (%)
 S1 – Bulbar 215 (67.4)
 S2 – Penile 43 (13.5)
 S3 – Pan-urethral 2 (0.6)
 Membranous 11 (3.4)
 Prostatic 5 (1.6)
 Bladder neck 43 (13.5)
Etiology (%)
 E1 – External trauma 16 (5.0)
 E2 – Idiopathic 89 (28.1)
 E3a – Internal trauma 39 (12.3)
 E3b – Recurrent stricture 81 (25.6)
 E3c – Radiation 71 (22.4)
 E4 – Infectious/Inflammatory 3 (0.9)
 E5 – Hypospadias repair 8 (2.5)
 E6 – Lichen sclerosus 10 (3.2)
LSE stage
 1 65 (21.1)
 2 152 (49.4)
 3 19 (6.2)
 4 23 (7.5)
 5 2 (0.6)
Prior urethroplasty (%)* 87 (27.3)
Prior dilation/DVIU (%) 195 (61.1)
Prior bladder neck repairs (%) 4 (1.3)
Pre-Optilume treatment (%)
 Balloon dilation 149 (50.3)
 DVIU 73 (24.7)
 None 74 (25.0)
DCB type (%)
 18 Fr, 3 cm 1 (0.3)
 24 Fr, 3 cm 8 (2.8)
 24 Fr, 5 cm 41 (14.1)
 30 Fr, 3 cm 47 (16.2)
 30 Fr, 5 cm 191 (65.9)
 36 Fr, 3 cm 1 (0.3)

BMI, body mass index; DVIU, direct visual internal urethrotomy; IQR, interquartile range.

*

Patients with the history of urethroplasty where involved segment is not associated with prior areas of reconstruction.